Free Trial

10 Best Penny Stocks to Buy Now - 3 of 10

 
 

Allurion Technologies (NYSE:ALUR)

Number of Upgrades from Top-Ranked Analysts
5 (in the last 90 days)
Consensus Rating
Buy
Rating Score
3.0
Ratings Breakdown
4 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$2.88 (632.7% Upside)

About Allurion Technologies

Allurion Technologies logoAllurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
11/14/2024Chardan CapitalDowngradeBuy ➝ Neutral
10/2/2024TD CowenInitiated CoverageBuy$2.00
9/6/2024Roth CapitalUpgradeStrong-Buy
9/6/2024Roth MkmInitiated CoverageBuy$2.00
8/22/2024Chardan CapitalLower Price TargetBuy ➝ Buy$5.00 ➝ $2.50
5/15/2024Chardan CapitalReiterated RatingBuy ➝ Buy$5.00 ➝ $5.00
4/4/2024Chardan CapitalInitiated CoverageBuy$5.00
2/9/2024Jefferies Financial GroupInitiated CoverageBuy$5.00
 

This company will win the AI race (Ad)

Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.

You must read this new presentation from Porter Stansberry.